Randomized trial characterizes the exposure-response and efficacy of ecopipam in adults and pediatrics with Tourette’s Syndrome, suggesting potential treatment benefits.
To characterize the E-R relationship of ecopipam in TS patients, to identify any differences between adult and pediatric patients, and to perform clinical trial simulations to add to the weight of efficacy in adults with TS.
No takes yet. Share an insight, caveat, or question.
Wanaski et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: